samedan logo
 
 
spacer
home > pmps > spring 2003 > child-resistant blister packs
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Child-Resistant Blister Packs

In recent years claims that non-reclosable flexible packaging for pharmaceutical solid dose products - in particular blisters - are not child safe have become more frequent. The Child Safety Packaging Group in the UK has been lobbying for a relative standard since 1995 and increased their activities following the lethal ingestion of 44 tablets containing ferrous-sulphate by a three year old boy - tablets that had allegedly been packed in blisters, although no evidence to prove this was produced.

Following a public debate it was decided that the UK would introduce a British standard and not wait for the Centre Européen de Normalisation (CEN) to present a European standard so that the MCA could revise its legislation.

The idea of child-resistant packaging was first introduced in the US by the Code of Federal Regulation in 1974. While the importance and benefits of legislation are widely accepted and regulation regarding potentially harmful household product is covered by EU Directives, only four member states have legislation covering pharmaceuticals. Germany introduced DIN 55559 in 1980 with the Netherlands following closely behind. In Italy testing does not allow the involvement of children but accepts child-resistant packaging as soon as it has been recognised as being child-resistant in another EU member state.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Tassilo Korab, Director, Head of the Business Unit Pharma Packaging at Teich


After studying Economics in Vienna, Tassilo Korab started his career as an International Sales Manager and has been in the packaging industry for more than 15 years. Now based at Teich in Austria, he is responsible for pharmaceutical packaging materials produced by Constantia Verpackungen AG, of which Teich is part.


spacer
Tassilo Korab
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Virisure & Bionique Join Forces

VIENNA, AUSTRIA – 15th December 2021 – Asahi Kasei Medical Co., Ltd (Asahi Kasei Medical) announced today the acquisition of Bionique Testing Laboratories LLC, a US-based leader in mycoplasma testing services for the biologics and life-sciences industries. Bionique joins ViruSure GmbH as part of the global biosafety testing services unit of Asahi Kasei Medical’s Bioprocess Division. Both Bionique and ViruSure will continue operations under their existing, widely respected brands.
More info >>

White Papers

Driving ROI: The Case for Investing in Contract & Site Regulatory Document Management Services

DrugDev

With tight timelines and complicated regulatory documentation requirements, getting a clinical trial up and running quickly is easier said than done. Key milestones can be achieved only after the successful negotiation of clinical trial agreements and completion of essential regulatory documents. Many clinical trials are hindered by inefficient, labor-intensive processes. Prolonged, inefficient activation can hamper investigator satisfaction and, ultimately, have a negative bottom-line impact for sponsors and CROs. In addition, the Sunshine Act is heightening the importance of financial disclosure in clinical trials. Without a robust financial disclosure strategy, sponsors cannot ensure that physician self-reported financial disclosure data are aligned with the payment data being reported through the Sunshine Act, increasing financial and regulatory risk.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement